In this episode of Inside the Microcap Markets, Joseph Lucosky examines one of the most controversial proposals currently facing the microcap market: Nasdaq’s proposed $5 million market capitalization delisting rule and the growing pushback it is generating across the public company ecosystem.

What may appear to be a straightforward effort to improve market quality has quickly evolved into a much larger debate about capital formation, investor protection, and whether current market structure policies align with Washington’s stated goal of helping more companies access and remain in the public markets. Drawing from recent meetings on Capitol Hill, Joseph discusses why this issue has become more than just a Nasdaq rule filing and what it could mean for emerging growth companies moving forward.

In this episode, Joseph covers:

• What Nasdaq’s proposed $5 million market cap rule would actually do
• Why critics believe the proposal creates an automatic delisting cliff
• How the rule could impact emerging growth and innovation companies
• The potential effects on capital raising, liquidity, and investor confidence
• Why the proposal is attracting attention from policymakers in Washington

As regulators, exchanges, and lawmakers continue debating the future of the public markets, the outcome of this proposal could have significant implications for smaller public companies and the broader emerging growth ecosystem. For founders, boards, investors, and advisors, understanding the stakes has never been more important.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com

In Episode 2 of Inside the Microcap Markets, Joseph Lucosky breaks down the real story behind Q1 2026 and why the microcap market isn’t disappearing, it’s evolving.

While traditional microcap IPO activity dropped dramatically year over year, the broader market tells a much different story. As exchanges continue tightening standards and increasing discretionary review, founders, bankers, and advisors are increasingly turning toward alternative pathways like uplistings, cross listings, and direct listings.

Joseph explains how the market has moved from a volume-driven environment to a far more selective and strategic one, where structure, positioning, and pathway analysis now matter more than ever.

In this episode, Joseph covers:

• Why Q1 2026 was not simply a “slower” market
• The dramatic decline in traditional microcap IPO volume and what caused it
• How Nasdaq and NYSE rule changes reshaped the landscape
• Why uplistings, cross listings, and direct listings surged in activity
• The growing importance of pathway analysis for founders and advisors
• How foreign private issuers are adapting to the new environment
• Why bigger deals are increasingly favored in today’s market
• What founders, boards, bankers, and consultants should be doing differently right now

Traditional IPO volume may have declined, but activity across alternative pathways accelerated as the market adapted to a more selective and strategic environment. Companies approaching the public markets in 2026 are facing a very different landscape than they were even a year ago, one where structure, positioning, and execution strategy play a far greater role in determining which deals move forward.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com.

The microcap market isn’t closed, but it’s no longer playing by the old rules.

In this first episode of Inside the Microcap Markets, Joseph Lucosky breaks down what’s really happening behind the scenes as the microcap markets move from a rules-based system to a discretionary one, and what that means for founders, boards, and deal teams trying to get public today.

From the outside, the market looks active. But beneath the surface, scrutiny is higher, timelines are longer, and the bar to list has fundamentally changed. You can no longer just check boxes, deals are being evaluated holistically, from management teams and capital structure to advisors and investor quality.

Joseph shares a real-time view from the trenches, including:

• Why hitting minimum listing requirements is no longer enough
• How Nasdaq’s new discretionary rule (IM-5101-3) is reshaping the process
• What separates deals that get approved from those that stall
• The biggest mistake founders and advisors are still making
• The three critical moves every company should make right now

This isn’t a shutdown, it’s an upgrade. The market is recalibrating. The bar is being raised across the entire ecosystem. And the companies that recognize that change early, and prepare for it with the right structure, the right team, and the right advisors, are the ones that will get through.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com.